These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 325827)

  • 1. Allograft enhancement by treatment with donor antigens extracted from alloantisera immune complexes.
    Debray-Sachs M; Liegeois A; Arnould A
    Transplant Proc; 1977 Mar; 9(1):953-6. PubMed ID: 325827
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction of immunologic enhancement in rats by use of antigen-antibody complexes.
    Marquet RL; Heystek GA; van Leersum RH
    Transplant Proc; 1977 Mar; 9(1):949-51. PubMed ID: 325826
    [No Abstract]   [Full Text] [Related]  

  • 3. Humoral factors. Immunologic enhancement.
    Batchelor JR; Welsh KI; Burgos H
    Transplant Proc; 1977 Mar; 9(1):931-6. PubMed ID: 141143
    [No Abstract]   [Full Text] [Related]  

  • 4. Allograft enhancement by pretreatment with donor antigens in the form of immune complexes.
    Liégeois A; Debray-Sachs M; Lecompte Y; Escourrou J; Hamburger J
    Surg Forum; 1975; 26():343-4. PubMed ID: 766267
    [No Abstract]   [Full Text] [Related]  

  • 5. Graft persistence effectively induces and maintains donor-specific unresponsiveness.
    Nishinaka H; Nakafusa Y; Hirano T; Takeda K; Kawano R; Nakano M; Arima T; Nakamura K; Kamei T; Tanaka M
    J Surg Res; 1997 Mar; 68(2):145-52. PubMed ID: 9184673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific immunosuppression of cardiac allograft rejection in rats.
    Jenkins AM; Woodruff MF
    Transplant Proc; 1973 Mar; 5(1):727-32. PubMed ID: 4144462
    [No Abstract]   [Full Text] [Related]  

  • 7. Pretransplant portal venous administration of donor antigen and portal venous allograft drainage synergistically prolong rat cardiac allograft survival.
    Kamei T; Callery MP; Flye MW
    Surgery; 1990 Aug; 108(2):415-21; discussion 421-2. PubMed ID: 2382235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immune sera, such as antilymphocyte serum, may contain antigen-antibody complexes].
    Debray-Sachs M
    Pathol Biol (Paris); 1977 Mar; 25(3):191-4. PubMed ID: 323789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of antibodies in the rejection and enhancement of rat organ allografts: non-Ag-B (Ia) antigens.
    Carpenter CB; Soulillou JP; D'Apice AJ; Strom TB; Garovoy MR
    Transplant Proc; 1976 Jun; 8(2):199-205. PubMed ID: 779180
    [No Abstract]   [Full Text] [Related]  

  • 10. Presentation of donor major histocompatibility complex antigens by bone marrow dendritic cell-derived exosomes modulates allograft rejection.
    Pêche H; Heslan M; Usal C; Amigorena S; Cuturi MC
    Transplantation; 2003 Nov; 76(10):1503-10. PubMed ID: 14657694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral factors in specific unresponsiveness to transplantation antigens.
    Brent L; Kilshaw PJ
    Transplant Proc; 1976 Jun; 8(2):209-15. PubMed ID: 779181
    [No Abstract]   [Full Text] [Related]  

  • 12. Dose-dependent effect of intrathymically injected 3-mol/L KCl-extracted histocompatibility antigens to prolong heart allograft survival in rats.
    Hamashima T; Stepkowski SM; Kahan BD
    Transplant Proc; 1995 Feb; 27(1):134-5. PubMed ID: 7878904
    [No Abstract]   [Full Text] [Related]  

  • 13. Enhancement of rat renal allograft with antibodies directed against erythrocyte-associated antigens (EAA).
    Jeekel J; van Dongen J; Majoor G; Harder F
    Transplant Proc; 1977 Mar; 9(1):969-72. PubMed ID: 325830
    [No Abstract]   [Full Text] [Related]  

  • 14. Immune responsiveness and active enhancement of rat renal allografts with soluble specific antigen.
    von Haefen U; Shaipanich T; Wren S; Busch G; Kim JP; Wilson RE
    Transplant Proc; 1973 Mar; 5(1):573-6. PubMed ID: 4144459
    [No Abstract]   [Full Text] [Related]  

  • 15. Suppressor cells and intrathymic inoculation of donor alloantigens in cardiac transplantation.
    Shen Z; Mohiuddin M; DiSesa VJ
    Ann Thorac Surg; 1995 Dec; 60(6):1683-5. PubMed ID: 8787463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological enhancement of renal allografts.
    Stuart FP; McKearn TJ; Fitch FW
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):53-8. PubMed ID: 4140597
    [No Abstract]   [Full Text] [Related]  

  • 17. Active or passive enhancement and allograft survival.
    Wilson RE
    Transplant Proc; 1972 Dec; 4(4):513-5. PubMed ID: 4405144
    [No Abstract]   [Full Text] [Related]  

  • 18. Production of antiidiotypic antibodies in the rat: in vitro characterization of specificity and correlation with in vivo specific suppression of cardiac allograft immune reaction across major histocompatibility complex.
    Wasfie T; Reed E; Suciu-Foca N; Hardy MA
    Surgery; 1990 Aug; 108(2):431-40; discussion 440-1. PubMed ID: 2143319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the effect of anti-B-cell alloantisera in rats.
    Aboul-Enein A; Sakai A; Butt K; Kountz SL
    Transplant Proc; 1979 Jun; 11(2):1426. PubMed ID: 157579
    [No Abstract]   [Full Text] [Related]  

  • 20. Duration of donor-specific tolerance after intrathymic administration of alloantigen.
    Arima T; Nakafusa Y; Goss JA; Walp LA; Yu S; Flye MW
    Transplant Proc; 1995 Feb; 27(1):136-7. PubMed ID: 7878912
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.